Results 41 to 50 of about 18,847 (260)
Temporal triangular alopecia: A rare entity
Clinical Dermatology Review, 2023 Congenital triangular alopecia (CTA) presents as a localized nonscarring patch of alopecia. It is likely to be confused with alopecia areata. The case is being reported to increase awareness and familiarize clinicians about this rare condition of CTA ...
Sonia P Jain +2 more
doaj +1 more source
JEADV Clinical Practice, EarlyView.ABSTRACT Background There is a growing body of literature suggesting that GLP‐1 receptor agonists (GLP‐1RAs) may be associated with hair loss; however, primary literature is sparse. Additionally, it is not well‐established which types of hair loss may be associated with GLP‐1RA use. Objectives This study aims to assess associations between GLP‐1RAs and
Lauren M. Ching +2 more
wiley +1 more source
А choice of therapy for severe forms of alopecia area [PDF]
Vestnik Dermatologii i VenerologiiAlopecia areata is a chronic organ-specific autoimmune inflammatory disease with a genetic predisposition. Alopecia areata is characterized by damage to hair follicles, persistent or temporary non-scarring hair loss.
Yulia A. Gallyamova
doaj +1 more source
Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study
JEADV Clinical Practice, EarlyView.ABSTRACT Background Alopecia areata (AA) is a chronic autoimmune hair loss disorder. Patients with primary autoimmune diseases commonly use systemic immunomodulators to manage disease and have an increased risk of developing AA. Systemic immunomodulators have diverse immunologic effects, but their impact on AA risk is not well understood. Objectives We
Angela Rose Liu +2 more
wiley +1 more source
Acta Dermato-VenereologicaThere are no updated epidemiological data on alopecia areata up to 2021. The objective of this study was to emphasize the urgency of addressing the evolving public health challenges of alopecia areata.
Dan Wang +4 more
doaj +1 more source
Dermatology and Therapy, 2023 Background Numerous studies have indicated that alopecia areata is associated with a chronic systemic inflammation, which is considered as a risk factor for venous thromboembolism.
Anna Waśkiel-Burnat +9 more
doaj +1 more source
Janus Kinase Inhibitors in the Treatment of Alopecia Areata
Prague Medical Report, 2023 Alopecia areata is a disease of autoimmune origin which causes non scarring hair loss. The extent of alopecia varies from a small patch to complete scalp and body hair loss, which can have huge psychosocial impact for those affected. Treatment modalities
Athanasios J. Stefanis
doaj +1 more source
Health‐Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan
The Journal of Dermatology, EarlyView.ABSTRACT Vitiligo is a disorder characterized by depigmentation of the skin and is known to impact patients' health‐related quality of life (HRQoL). In Japan, HRQoL studies on vitiligo remain limited in size and scope, and factors contributing to impaired HRQoL, as well as the psychological burden, have not been adequately evaluated.
Naoki Oiso +5 more
wiley +1 more source
Dermatology Practical & ConceptualIntroduction: Alopecia areata is a type of non-scarring alopecia, which is thought to be associated with T-cell mediated immune response. Objective: This study aims to compare the levels of serum inflammatory markers before and after treatment in ...
Icim Komurcugil, Nermin Karaosmanoğlu
doaj +1 more source
Alopecia Areata Associated with Localized Vitiligo
Case Reports in Dermatology, 2010 Alopecia areata is a common cause of noncicatricial alopecia that occurs in a patchy, confluent or diffuse pattern. It may occur as a single, self-limiting episode or may recur at varying intervals over many years. The association of alopecia areata with
Shankarling D. Kuchabal, D.S. Kuchabal
doaj +1 more source